– Achieved $4.9 Million in Total Revenue, Including $3.6 Million in Net Revenue from Sales of COSELA (trilaciclib) –
– Announced Supplemental COSELA Sales Force to Target Top Tier Accounts and Publication of Permanent J-Code for COSELA –
– Initiation of…

Click here to view the original article.